Columbia Laboratories, Inc. (CBRX) Narrows Q4 Loss by 5c/Share; Revs Lighten

Columbia Laboratories, Inc. (NASDAQ: CBRX) reported Q4 EPS of ($0.01), versus ($0.06) reported last year. Revenue for the quarter came in at $6.4 million, versus $14.9 million reported last year.

For earnings history and earnings-related data on Columbia Laboratories, Inc. (CBRX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
• Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance